What is the recommended dose and frequency of Nebivolol (nebivolol) for hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dose and Frequency of Nebivolol for Hypertension

The recommended starting dose of nebivolol for hypertension is 5 mg once daily, with or without food, as monotherapy or in combination with other agents. 1

Dosing Guidelines

  • Initial dose: 5 mg once daily 1, 2
  • Titration: Dose can be increased at 2-week intervals if needed 1
  • Maximum dose: Up to 40 mg daily, though doses beyond 10 mg provide limited additional benefit 1, 3
  • Administration: Can be taken with or without food 1

Special Population Considerations

Renal Impairment

  • Severe renal impairment (CrCl <30 mL/min): Start with 2.5 mg once daily and titrate slowly if needed 1
  • Not studied in dialysis patients - use with caution 1

Hepatic Impairment

  • Moderate hepatic impairment: Start with 2.5 mg once daily and titrate slowly if needed 1
  • Not recommended in severe hepatic impairment 1

Elderly Patients

  • No dose adjustment necessary for elderly patients 1

CYP2D6 Poor Metabolizers

  • No dose adjustments necessary as clinical effect and safety profile are similar to extensive metabolizers 1

Clinical Efficacy

  • Nebivolol 5 mg once daily reduces resting diastolic blood pressure as effectively as standard therapeutic dosages of atenolol, metoprolol, lisinopril, and nifedipine 2
  • Response rates range from 58% to 81% after 4 to 52 weeks of treatment 2
  • Nebivolol has an additive effect when combined with hydrochlorothiazide 2, 4
  • The 5 mg dose is therapeutically equivalent to metoprolol 50 mg once daily 5

Mechanism and Benefits

  • Nebivolol is a highly selective β1-receptor blocker with nitric oxide-mediated vasodilatory effects 2, 4
  • The vasodilatory properties may contribute to its favorable hemodynamic profile compared to traditional beta-blockers 4, 6
  • Produces less impact on augmentation index (a measure of arterial stiffness) than atenolol 6
  • Does not significantly influence glucose or plasma lipid metabolism 2

Adverse Effects

  • Most common adverse events are transient headache, dizziness, fatigue, and paresthesias 2, 3
  • Generally well-tolerated with infrequent, mild to moderate side effects 2
  • No significant reports of orthostatic hypotension 2
  • Lower incidence of sexual dysfunction compared to some other beta-blockers 2

Clinical Pearls

  • For patients with hypertension and heart failure, nebivolol can be titrated up to 10 mg daily 5
  • When switching from metoprolol 50 mg, start with nebivolol 5 mg once daily 5
  • Nebivolol is administered as a racemic mixture of equal proportions of d- and l-enantiomers 2, 4
  • Metabolized primarily through CYP2D6 in the liver 4

Place in Therapy

  • Recommended as a useful first-line treatment option for mild to moderate uncomplicated essential hypertension 2, 4
  • May be particularly beneficial in patients who experience side effects with traditional beta-blockers 2
  • According to the 2024 ESC guidelines, nebivolol is one of the preferred vasodilating beta-blockers when beta-blockers are chosen for hypertension management 7

References

Research

Nebivolol: a new antihypertensive agent.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008

Guideline

Dosing Equivalence and Clinical Considerations for Nebivolol and Metoprolol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.